Filtros de búsqueda

Lista de obras de

Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland

artículo científico publicado en 2020

Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma

artículo científico publicado en 2016

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

artículo científico publicado en 2015

International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era ⬇️

artículo científico publicado el 6 de agosto de 2012

Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome

scientific article published on 05 August 2019

Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with "standard" immunochemotherapy: A large retrospective study from 4 institutions.

artículo científico publicado en 2017

Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)

scientific article published on 17 August 2020

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma

artículo científico publicado en 2020

The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association.

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda